☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

NPCi discusses Anticholinergics in COPD

The National Prescribing Centre (NPC) has published a Rapid Review discussing in detail the current concerns about inhaled anticholinergics in people with COPD and an increase in cardiovascular events.

The article details the background to the current concerns, provides a detailed interpretation of the latest information and highlights the limitations in the current data.

Action: Clinicians will find this article useful in reassuring patients. It is thorough and of the usual high standard expected of the NPC.

Share 'NPCi discusses Anticholinergics in COPD' by emailShare 'NPCi discusses Anticholinergics in COPD' on FacebookShare 'NPCi discusses Anticholinergics in COPD' on TwitterShare 'NPCi discusses Anticholinergics in COPD' on LinkedInShare 'NPCi discusses Anticholinergics in COPD' on reddit


No Comments to “NPCi discusses Anticholinergics in COPD”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.